InflaRx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.About IFRX
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab.
CEONiels Christoph Riedemann
CEONiels Christoph Riedemann
Employees74
Employees74
HeadquartersJena, Thueringen
HeadquartersJena, Thueringen
Founded2007
Founded2007
Employees74
Employees74
IFRX Key Statistics
Market cap54.29M
Market cap54.29M
Price-Earnings ratio-0.77
Price-Earnings ratio-0.77
Dividend yield—
Dividend yield—
Average volume170.24K
Average volume170.24K
High today$0.8143
High today$0.8143
Low today$0.7938
Low today$0.7938
Open price$0.813
Open price$0.813
Volume51.61K
Volume51.61K
52 Week high$2.82
52 Week high$2.82
52 Week low$0.7113
52 Week low$0.7113
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own IFRX. This list is generated using Robinhood data, and it’s not a recommendation.